What Do We Know About the Merck Covid pill?

What Do We Know About the Merck Covid pill?
SHARE

The U.S pharmaceutical company Merck has been working on a Covid pill known as molnupiravir. The European Medicines Agency (EMA) is reviewing data offered by Merck to determine the safety and efficiency of the COVID pill. Merck announced that the Covid pill reduces hospitalizations by half and prevents deaths. 

The experimental molnupiravir pill could help control the pandemic

The Drugmaker said the data from trials would soon be submitted to the FDA and that the pill would be the first of its kind to control the virus. The already approved Covid-19 treatments require injection or IV treatment, while the pill requires oral administration. The results of the trials were positive, and Merck’s CEO, Robert Davis, declared that the pill could help people worldwide deal with Covid-19 symptoms. The treatment could greatly help the overwhelmed medical facilities, especially in countries with fragile health systems.

More on the clinical trial

For the clinical trial, Merck collaborated with Ridgeback Biotherapeutics. Participants who were given molnupiravir within five days from the first symptoms needed less hospitalization than those given a placebo. The hospitalization and death rates decreased by almost 50% for those who received the pill. The 775 participants were adults suffering mild and severe Covid-19 infections, with underlying health conditions such as diabetes, heart disease, and obesity. 

The participants were not vaccinated against the COvid-19 virus during the clinical trial

Reports mention that the 775 participants had not been previously vaccinated against the Covid-19 virus. The data will be submitted to the FDA, and the health regulator might authorize it in the future. Once approved, the oral pill would be less expensive but as efficient as other current Covid-19 treatments requiring medical providers to administer them to patients. However, health experts remind everyone that the pills would complement Covid-19 vaccines, not replace them. Vaccination remains the first weapon against the SARS-CoV-2 virus. 


SHARE
Jeffrey Olmsted

Jeffrey likes to write about health and fitness topics, being a champion fitness instructor in the past.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.